Thus, TSLP may exert adverse effects on the clinical outcomes in patients with sepsis with an intense immune response, which may lead to secondary systemic inflammatory response syndrome and secondary multiple organ failure. This evidence concerns the gene TSLP and systemic inflammatory response syndrome.